Case Study: a pharmaceutical maker boosts production and speeds validation with RoviSys DeltaV control system overhaul

Pharmaceutical Maker boosts production 25% in 12 months with RoviSys

A pharmaceutical maker was stymied by an unreliable, aging control system that prevented it from effectively introducing new critical therapy drugs into production at its California facility. The heavily-regulated process for validating new drugs required a consistent and reliable system, which the outdated infrastructure could not provide. The company engaged RoviSys to execute a full control system reboot.

RoviSys designed and implemented a complete DeltaV control system overhaul in just 12 months. The solution automated bioreactors and cleaning processes, implemented electronic batch records, and provided system support for testing and qualification. As a result, the facility gained the ability to manufacture multiple products in a suite designed for one and increased production by up to 25%. The automation also significantly decreased the risk of human error in batch reporting.